Barrx Medical Inc.
Division of Medtronic PLC
Latest From Barrx Medical Inc.
The week's round-up includes a new CEO at Synthorx Inc., new sales executives at Aerie Pharmaceuticals and board appointments at BTG, Pertinax Pharma, Realm Therapeutics, Breath Therapeutics, iOnctura, NBE Therapeutics and Inflazome.
The increasing prevalence of MIS and the opportunity for greater MIS penetration in existing procedures translate into significant growth potential for the MIS products market in the years ahead. Despite some challenges, device manufacturers are driving growth in the market by targeting key procedures and geographies with new robotic surgery systems and robotic-like technologies designed to enable more complex procedures to be performed via an MIS approach.
The $860 million purchase agreement will give Covidien the dominant capsule endoscopy platform on the market as the company hopes for FDA approval this year of PillCam COLON 2 as a less invasive alternative for patients who are unable to undergo a colonoscopy.
At the end of October, Apollo Endosurgery announced that it would acquire certain obesity assets from Allergan: Lap-Band, one of the most well-known brands in bariatric surgery, and Orbera, Allergan’s intra-gastric balloon system, the leading such product in Europe. It’s not unusual these days for large companies to unload under-performing businesses, but the Allergan deal is striking because of its choice of partner – Apollo Endosurgery is a small organization acquiring a much larger one.
- Radiofrequency Devices
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Medtronic PLC
- Senior Management
Robert C Haggerty, VP, Bus. Dev.
David S Utley, MD, CMO
Darin Wilson, VP, Int'l. Sales & Mktg.
Richard Short, VP, Fin.
- Contact Info
Barrx Medical Inc.
Phone: (888) 662-2779
540 Oakmead Pkwy.
Sunnyvale, CA 94085
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.